Chicago:- A new study co-led by an urologist and a radiation oncologist at Memorial Sloan-Kettering Cancer Center shows that the specialty of the physician patients see can influence the type of therapy they ultimately receive. The study analyzed men with localized prostate cancer. It found that men aged 65 to 69 years who consult an urologist are more likely to undergo surgery to remove the prostate. Others, regardless of age, who consult a radiation oncologist and an urologist, usually receive radiation therapy.
"These practice patterns are no surprise but are notable because specialists who treat prostate cancer tend to favor the treatment they themselves deliver, despite the fact that no one has shown one treatment for early stage prostate cancer to be better than another," said Thomas L. Jang, MD, MPH, a physician in the Department of Urology, at Memorial Sloan-Kettering and co-lead author of the study. "It is very important for patients to receive an unbiased, balanced perspective on the full range of treatments."
The study, presented at the annual meeting of the American Society of Clinical Oncologists, reviewed the records of 85,088 men aged 65 and older who were diagnosed with prostate cancer between 1994 and 2002 using information from the SEER (Surveillance, Epidemiology, and End Results) Medicare-linked database to determine the type of specialist they saw and the therapy they received. The treatments included radical prostatectomy (surgery to remove the prostate), radiation therapy, primary androgen deprivation (hormone) therapy, and expectant management (watchful waiting).